Personalising Psychotherapy for Chronic Primary Pain Using Network Analysis
NCT ID: NCT06179784
Last Updated: 2023-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
12 participants
INTERVENTIONAL
2023-11-17
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is the study procedure accepted by and feasible for CPP patients as well as their therapists?
* Does the personalised psychotherapy with databased clinical decisionmaking lead to significant improvement?
Participants will go through several study phases:
* Pretest and informational meeting with study management
* Baseline 1: answering a questionnaire six times a day for 21 days in daily life on their mobilephone (EMA); this data will be used for the calculation of a network for each participant, that in turn will be used to select the treatment target and according treatment intervention as suggested by an algorithmic decisiontool
* Probatory therapy phase: three weekly sessions with therapist; questionnaire three times a week
* Baseline 2: questionnaire three times a week
* Therapy phase: up to ten sessions with therapist; questionnaire three times a week
* Post phase: posttest, two weeks of three weekly assessments, then another 21 days EMA; two monthly booster sessions with therapist
* Follow-up: posttest and meeting with study management
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The treatment of chronic primary pain (CPP) with Cognitive Behaviour Therapy (CBT) is effective, yet effects remain small to moderate. New approaches to the treatment of CPP are needed. They should include an orientation toward processes instead of symptoms and strategies for personalisation. This paradigm shift requests precisce, testable models that allow to link treatment procedures to psychological changes. Unfortunately, current models are rather vague about specific, especially temporal pathways by which its elements interact, or the pathways are not as simplistic as proposed. Therefore, multiple variables and pathways related to the development and persistence of pain-related disabilities should be considered.
One approach to individualisation makes use of repeated measures in the daily lives of patients, which enable the usage of network analysis to investigate interactions between symptoms/processes of a patient. Process-oriented, individualised, network-based therapy for CPP (POINT Pain) combines process-oriented measurements to individualise therapy with network-based analysis approaches for target and treatment selection. We propose the following hypotheses:
1. In line with previous research, we assume that the implementation of POINT Pain is feasible for and accepted by patients as well as therapists. Feasibility and acceptance are indicated by mean ratings of at least 3.5 out of 5 across all items of one scale (each rated on 1-5 Likert scales) on a feedback form developed for this study and by positive comments to open ended questions.
2. Furthermore, we expect POINT Pain to lead to clinically significant improvements as compared to baseline, i.e. decreasing scores in the outcome measures. According to current recommendations, the improvement will be operationalised as effect-size estimated with Hedge's g, the significance with Tau-z.
Procedure:
Before participants are enrolled in the study, they will have two sessions with the study management for diagnostics, pretest, and individualisation of and instructions to the questionnaire.
An ABA'C Multiple Baseline design is chosen to evaluate the effect of individually selected therapy interventions:
Firstly, a baseline assessment (A) is conducted over the period of 21 days six times per day using EMA. In the EMA, a previously validated and piloted questionnaire with items on treatment relevant pain processes is implemented. It contains processes derived from the most prominent psychological models of chronic pain, as there is no overarching theoretical framework adressing the interaction of multi-dimensional pain processes yet. For the EMA, the waking hours of the participants will be divided into six equal time intervals within which the signals for the questionnaires will be randomised (semi randomisation). After completion of phase A, an individual network will be computed.
Secondly, the probatory phase (B) is initiated after completion of phase A. After this phase, an application for psychotherapy is sent to the patient's insurance agency. As much information is already available from phase A, phase B will comprise three sessions. Participants will switch from EMA to SCED assessment in phase B, which means they will answer the same questionnaire as before three times a week, two of which during the week and one on the weekend. The timepoints for the questionnaires will again be semi-randomised during the waking hours of the participants. This procedure stays the same for the remaining phases.
As there is often a natural break between the probatory and the treatment phases due to the psychotherapy application, another baseline (A') is implemented after phase B. The duration of this second baseline will be semi-randomised between one and three weeks.
There are several possibilities for the selection of the most relevant or central variable in a network. The clinical decision regarding treatment target and module will be based on an algorithmic decision-tool which will is programmed based on experts' ratings (see preregistration: https://doi.org/10.17605/OSF.IO/BNFWY). Possible interventions will be limited to a pre-defined intervention pool that was developed based on common therapy manuals for chronic pain. Therapist and supervisor can only rule out the module suggested by the algorithmic decision-tool if there are serious concerns regarding potential harms (e.g. red flags rule out exposure in vivo).
At last, the treatment phase (C) is realised. The selected intervention is carried out until clinically significant improvement is reached or until a maximum of ten sessions has been conducted.
For all assessments using the EMA questionnaire (i.e. phases A to C), the software m-Path (https://m-path.io/landing/) published by KU Leuven will be used.
In addition to the aforementioned assessments, participants will complete traditional outcome measures at three timepoints, i.e. before phase A (pretest), after phase C (posttest), and three months after finishing phase C (follow-up). After phase C, participants will have two more weeks of SCED, after which they will undergo another EMA phase of 21 days with a frequency of six assessments per day in order to calculate a post-therapy network. During this study phase, two monthly booster-sessions with their therapist will take place, but there will not be any further intervention, only monitoring.
The results of the weekly SCED assessments will be analysed in a timely manner and discussed with the participants regularly.
Feasibility and acceptance will be evaluated post-treatment and at follow-up. A feedback form developed for this study will be used for quantitative and qualitative assessment.
Participants:
Patients will be recruited via the waiting list of the university's outpatient clinic, in cooperation with other currently running studies at the same university recruiting chronic pain patients, and via various media (e.g. newspaper articles) and doctors' offices. Study therapists will be recruited in the university's outpatient clinic as well. Inclusion criteria for patients are at least 18 years of age, having access to a smartphone, and the main diagnosis of chronic pain. The diagnosis will be checked using the brief version of the Diagnostic Interview for Mental Disorders (Mini-DIPS). For patients recruited via the waiting list, screening for suitability will take place during the first consultation at the university psychotherapy training centre's outpatient clinic. Suitable participants will be informed about the study and referred if they agree to be contacted. Furthermore, patients that had to be excluded from other currently running studies will be referred if they agreed to be contacted as well.
Analysis:
In the context of SCEDs, each individual can be analysed separately. Especially regarding the qualitative measurements (acceptance, feasibility), it can be assumed that a sample of twelve will lead to a saturation in obtainable answers. Thus, all hypotheses can be answered with a sample of twelve: (1) We can evaluate whether the study procedure is feasible and accepted by patients and therapists, and (2) within SCED clinically significant change can be evaluated per individual. Of course, SCED results will not be generalizable to other individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure in vivo
The goal of the exposure in vivo treatment module is the correction of irrational, fearful beliefs regarding movements, a reduction of avoidance behaviours and hence a facilitation of activity levels. This will be done by carrying out feared, avoided movements and seeking out avoided situations and places. Exemplary units are the development of a movement hierarchy and protocols for exposure exercises.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Relaxation
Goal of the relaxation treatment module is the reduction of stress and tension, which will be achieved applying relaxation techniques such as Progressive Muscle Relaxation (PMR), breathing techniques, and imaginary methods.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Activity and Rest
The treatment module activity and rest is based on pacing and pursues the goal to balance active and resting phases. For overly active patients, the module will consist of implementing breaks and resting phases, while for overly resting patients the module will consist of graduated activity build-up. Acitivity protocols, plans, and exercises will be used.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Cognitive Coping with Pain
Goal of the treatment module cognitive coping with pain is the reduction of rigid, dysfunctional thought patterns by flexibilising them and implement functional thought patterns instead. It includes classical methods such as cognitive restructuring as well as meta-cognitive or defusion techniques.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Attention Control
The goal of the treatment module attention control is to enable patients to willingly draw their attention towards other entities as their pain or perceive their pain in a non-judgmental way, thus improve their coping strategies and enhance functioning levels. Exemplary units are the anti-pain diary or the distraction alphabet.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Activating Resources
The goal of the activating resources module is relief and a balance between unpleasant perceptions as pain and pleasent experiences. This will be achieved by reactivating lost resources and implementing new ones, e.g. social networks or hobbies. Exemplary units are the positive diary or focusing on healthy bodyparts.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Acceptance
Goal of the acceptance module is the flexibilisation of thought patterns by regaining mental resources through givign up inner resistance against the pain. Patients will be supported in developing an accepting attitude towards their suffering using working units like the monster by the wayside or concluding a peace treaty with oneself.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Values and Values-based Action
Goal of the treatment module values and values-based action is enhancing satisfaction with life and regaining action control. Patients will learn about their personal values and how they can align their actions with them. Exemplary units are sorting values, a value diary, or looking back on one's life.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Sleep
Goal of the treatment module sleep is enhancing the subjective sleep quality and increase the feeling of recovery. Patients will learn about sleep hygiene, stimulus control, and imaginary techniques such as the inner feel-good place.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Selfcompassion
Goal of the selfcompassion treatment module is the development of a benevolent, loving, and kind attitude towards oneself and one's suffering in order to enhance wellbeing and feelings of self-worth. Exemplary units are the selfcompassion break, writing a letter to oneself, or changing perspective.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behaviour Therapy including third-wave
All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subjective impairment/disability (yes-no)
* access to a smartphone compatible with the app mPath
Exclusion Criteria
* only migraine/headache or migraine/headache are the focus of pain
* analphabetism
* insufficient German knowledge
* current psychotherapy
* current participation in another intervention study
* physical inability to take part in therapy and study sessions
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. Julia Glombiewski
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Julia Glombiewski
Clinical professor, Head of department clinical psychology and psychotherapy for adults
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RPTU Kaiserslautern-Landau, Klinische Psychologie und Psychotherapie des Erwachsenenalters
Landau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Verena E Hofmann, M. Sc.
Role: primary
Saskia Scholten, PhD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Akerblom S, Perrin S, Rivano Fischer M, McCracken LM. Predictors and mediators of outcome in cognitive behavioral therapy for chronic pain: the contributions of psychological flexibility. J Behav Med. 2021 Feb;44(1):111-122. doi: 10.1007/s10865-020-00168-9. Epub 2020 Jul 8.
Williams ACC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007407. doi: 10.1002/14651858.CD007407.pub4.
Wright AGC, Woods WC. Personalized Models of Psychopathology. Annu Rev Clin Psychol. 2020 May 7;16:49-74. doi: 10.1146/annurev-clinpsy-102419-125032. Epub 2020 Feb 18.
Vlaeyen JWS, Crombez G. Behavioral Conceptualization and Treatment of Chronic Pain. Annu Rev Clin Psychol. 2020 May 7;16:187-212. doi: 10.1146/annurev-clinpsy-050718-095744. Epub 2019 Dec 10.
Wideman TH, Finan PH, Edwards RR, Quartana PJ, Buenaver LF, Haythornthwaite JA, Smith MT. Increased sensitivity to physical activity among individuals with knee osteoarthritis: relation to pain outcomes, psychological factors, and responses to quantitative sensory testing. Pain. 2014 Apr;155(4):703-711. doi: 10.1016/j.pain.2013.12.028. Epub 2013 Dec 28.
Beeckman M, Simons LE, Hughes S, Loeys T, Goubert L. A Network Analysis of Potential Antecedents and Consequences of Pain-Related Activity Avoidance and Activity Engagement in Adolescents. Pain Med. 2020 Feb 1;21(2):e89-e101. doi: 10.1093/pm/pnz211.
Liew BXW, Ford JJ, Briganti G, Hahne AJ. Understanding how individualised physiotherapy or advice altered different elements of disability for people with low back pain using network analysis. PLoS One. 2022 Feb 10;17(2):e0263574. doi: 10.1371/journal.pone.0263574. eCollection 2022.
Thompson EL, Broadbent J, Fuller-Tyszkiewicz M, Bertino MD, Staiger PK. A Network Analysis of the Links Between Chronic Pain Symptoms and Affective Disorder Symptoms. Int J Behav Med. 2019 Feb;26(1):59-68. doi: 10.1007/s12529-018-9754-8.
Borsboom D. A network theory of mental disorders. World Psychiatry. 2017 Feb;16(1):5-13. doi: 10.1002/wps.20375.
Carlin MT, Costello MS. Statistical Decision-Making Accuracies for Some Overlap- and Distance-based Measures for Single-Case Experimental Designs. Perspect Behav Sci. 2021 Nov 22;45(1):187-207. doi: 10.1007/s40614-021-00317-8. eCollection 2022 Mar.
Morley, S. (2018). Single-case methods in clinical psychology A practical guide (C. M., & C. J. M., Eds.). Routledge.
Margraf, J., Cwik, J. C., Suppiger, A., & Schneider, S. (2017). Mini-DIPS Open Access. Diagnostisches Interview bei psychischen Störungen [Short-Form of the Diagnostic Interview for Mental Disorders. Open Access]. https://www.kli.psy.ruhr-uni-bochum.de/dips-interv/klipsy/download/Mini-DIPS%20Open%20Access.pdf
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough?: An experiment with data saturation and variability. Field Methods, 18(1), 59-82. https://doi.org/10.1177/1525822X05279903
Turner-Bowker DM, Lamoureux RE, Stokes J, Litcher-Kelly L, Galipeau N, Yaworsky A, Solomon J, Shields AL. Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development. Value Health. 2018 Jul;21(7):839-842. doi: 10.1016/j.jval.2017.11.014. Epub 2018 Mar 7.
Anderson KO, Dowds BN, Pelletz RE, Edwards TW, Peeters-Asdourian C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain. 1995 Oct;63(1):77-83. doi: 10.1016/0304-3959(95)00021-J.
Nicholas MK. The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain. 2007 Feb;11(2):153-63. doi: 10.1016/j.ejpain.2005.12.008. Epub 2006 Jan 30.
Mangels, M., Schwarz, S., Sohr, G., Holme, M., & Rief, W. (2009). Der Fragebogen zur Erfassung der schmerzspezifischen Selbstwirksamkeit (FESS): Eine Adaptation des Pain Self-Efficacy Questionnaire für den deutschen Sprachraum. Diagnostica, 55(2), 84-93. https://doi.org/10.1026/0012-1924.55.2.84
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. doi: 10.1016/j.pain.2004.09.012. No abstract available.
Tait RC, Chibnall JT, Krause S. The Pain Disability Index: psychometric properties. Pain. 1990 Feb;40(2):171-182. doi: 10.1016/0304-3959(90)90068-O.
Mewes R, Rief W, Stenzel N, Glaesmer H, Martin A, Brahler E. What is "normal" disability? An investigation of disability in the general population. Pain. 2009 Mar;142(1-2):36-41. doi: 10.1016/j.pain.2008.11.007. Epub 2009 Jan 14.
Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987 Aug;30(2):191-197. doi: 10.1016/0304-3959(87)91074-8.
Speksnijder CM, Koppenaal T, Knottnerus JA, Spigt M, Staal JB, Terwee CB. Measurement Properties of the Quebec Back Pain Disability Scale in Patients With Nonspecific Low Back Pain: Systematic Review. Phys Ther. 2016 Nov;96(11):1816-1831. doi: 10.2522/ptj.20140478. Epub 2016 May 26.
Sielski R, Glombiewski JA, Rief W, Crombez G, Barke A. Cross-cultural adaptation of the German Pain Solutions Questionnaire: an instrument to measure assimilative and accommodative coping in response to chronic pain. J Pain Res. 2017 Jun 19;10:1437-1446. doi: 10.2147/JPR.S130016. eCollection 2017.
McCracken, L. M. (2005). Contextual cognitive-behavioral therapy for chronic pain. IASP Press.
Nicholas, M., Molloy, A., Tonkin, L., & Beeston, L. (2003). Practical and positive ways of adapting to chronic pain Manage your pain. Souvenir press.
Kleinstäuber, M., Thomas, P., Witthöft, M., & Hiller, W. (2018). Kognitive Verhaltenstherapie bei medizinisch unerklärten Körperbeschwerden und somatoformen Störungen (2. Aufl.). Springer.
Germer CK, Neff KD. Self-compassion in clinical practice. J Clin Psychol. 2013 Aug;69(8):856-67. doi: 10.1002/jclp.22021. Epub 2013 Jun 17.
Germer, C. K., & Neff, K. D. (2019). Mindful Self-Compassion (MSC). In I. Itzvan (Ed.), The handbook of mindfulness-based programs: Every established intervention, from medicine to education (357-367). Routledge.
Main, C. J., Keefe, F. J., Jensen, M. P., Vlaeyen, J. W. S., & Vowles, K. E. (2015). Fordyce's Behavioral Methods for Chronic Pain And Illness Republished with Invited Commentaries. IASP Press.
Hofmann VE, Glombiewski JA, Kininger F, Scholten S. How to personalise cognitive-behavioural therapy for chronic primary pain using network analysis: study protocol for a single-case experimental design with multiple baselines. BMJ Open. 2024 Dec 3;14(12):e089319. doi: 10.1136/bmjopen-2024-089319.
Related Links
Access external resources that provide additional context or updates about the study.
Preregistration of the algorithmic decision-tool
Preregistration of the EMA questionnaire development
Assessment app mPath
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POINT Pain
Identifier Type: -
Identifier Source: org_study_id